Literature DB >> 11929079

Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations.

K A Woeber1.   

Abstract

Although the normal thyroid gland secretes both levothyroxine (L-T4) and levotriiodothyronine (L-T3), normalization of serum TSH with L-T4-replacement therapy alone in hypothyroidism is generally believed to result in a normal serum L-T3 and to reflect a euthyroid state. However several recent studies suggest that this may not be the case. Accordingly, the relationship between serum free L-T4 and free L-T3 was examined in 20 normal individuals (group A) and in 53 patients with chronic autoimmune thyroiditis, 18 with normal TSH on no L-T4-replacement (group B), and 35 with normal TSH on L-T4-replacement therapy for hypothyroidism (group C). Data were analyzed by applying a one-way analysis of variance with correction for multiple comparisons. Serum TSH values were very similar among the 3 groups. In groups A and B, mean serum free T4 and free T3 were very similar. In group C, the mean free T4 (16+/-2 pmol/l) was significantly higher than the values in groups A (14+/-1) and B (14+/-2) (p<0.001) and the mean free T3 lower (4.0+/-0.5 pmol/l vs 4.2+/-0.5, NS and 4.4+/-0.5, p<0.02). Consequently, the mean molar ratio of free T4 to free T3 was significantly higher in group C than the ratios in groups A and B (p<0.0001), despite very similar TSH values. These findings indicate that in hypothyroid patients L-T4-replacement, that is sufficient to maintain a normal serum TSH, is accompanied by a serum free T4 that is higher than that in untreated euthyroid patients or normal individuals and may not result in an appropriately normal serum free T3 concentration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929079     DOI: 10.1007/BF03343972

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

Review 1.  The deiodinase family of selenoproteins.

Authors:  D L St Germain; V A Galton
Journal:  Thyroid       Date:  1997-08       Impact factor: 6.568

2.  Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?

Authors:  S Tigas; J Idiculla; G Beckett; A Toft
Journal:  Thyroid       Date:  2000-12       Impact factor: 6.568

3.  Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation.

Authors:  J M Stock; M I Surks; J H Oppenheimer
Journal:  N Engl J Med       Date:  1974-03-07       Impact factor: 91.245

Review 4.  Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones.

Authors:  P R Larsen
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

5.  Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.

Authors:  C J Pearce; R L Himsworth
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

6.  'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individuals.

Authors:  M Rendell; D Salmon
Journal:  Clin Endocrinol (Oxf)       Date:  1985-06       Impact factor: 3.478

7.  Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.

Authors:  R Bunevicius; G Kazanavicius; R Zalinkevicius; A J Prange
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

8.  Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis.

Authors:  A Pilo; G Iervasi; F Vitek; M Ferdeghini; F Cazzuola; R Bianchi
Journal:  Am J Physiol       Date:  1990-04

9.  Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans.

Authors:  L H Fish; H L Schwartz; J Cavanaugh; M W Steffes; J P Bantle; J H Oppenheimer
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

  9 in total
  21 in total

Review 1.  Novel insights into thyroid hormones from the study of common genetic variation.

Authors:  Colin M Dayan; Vijay Panicker
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

2.  A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.

Authors:  Vijay Panicker; Christie Cluett; Beverley Shields; Anna Murray; Kirstie S Parnell; John R B Perry; Michael N Weedon; Andrew Singleton; Dena Hernandez; Jonathan Evans; Claire Durant; Luigi Ferrucci; David Melzer; Ponnusamy Saravanan; Theo J Visser; Graziano Ceresini; Andrew T Hattersley; Bijay Vaidya; Colin M Dayan; Timothy M Frayling
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  An Inverse Relationship Between Weight and Free Thyroxine During Early Gestation Among Women Treated for Hypothyroidism.

Authors:  James E Haddow; Louis M Neveux; Glenn E Palomaki; Geralyn Lambert-Messerlian; Fergal D Malone; Mary E D'Alton
Journal:  Thyroid       Date:  2015-06-23       Impact factor: 6.568

Review 5.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

6.  Dual control of pituitary thyroid stimulating hormone secretion by thyroxine and triiodothyronine in athyreotic patients.

Authors:  Rudolf Hoermann; John E M Midgley; Johannes W Dietrich; Rolf Larisch
Journal:  Ther Adv Endocrinol Metab       Date:  2017-07-13       Impact factor: 3.565

7.  Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine.

Authors:  Martin Carlwe; Thomas Schaffer; Stefan Sjöberg
Journal:  Eur Endocrinol       Date:  2013-03-15

8.  Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis.

Authors:  Elizabeth A McAninch; Kumar B Rajan; Corinne H Miller; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2018-08-15       Impact factor: 5.958

9.  Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?

Authors:  Sarah J Peterson; Elizabeth A McAninch; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2016-10-04       Impact factor: 5.958

10.  Decreased Expression of Ileal Thyroid Hormone Transporters in a Hypothyroid Patient: A Case Report.

Authors:  Chae Won Chung; Eun Young Mo; Gyung Seo Jung; Yoo Hyung Kim; Sun Wook Cho; Do Joon Park; Jeong Mo Bae; Young Joo Park
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.